{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:06:21Z","timestamp":1785528381913,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T00:00:00Z","timestamp":1348531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00345-012-0949-3","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T13:15:14Z","timestamp":1348492514000},"page":"45-52","source":"Crossref","is-referenced-by-count":37,"title":["Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes"],"prefix":"10.1007","volume":"31","author":[{"given":"Fran\u00e7ois","family":"Audenet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Traxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,25]]},"reference":[{"key":"949_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10\u201329. doi: 10.3322\/caac.20138","journal-title":"CA Cancer J Clin"},{"key":"949_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0094-0143(21)01585-8","volume":"15","author":"JL Huffman","year":"1988","unstructured":"Huffman JL (1988) Ureteroscopic management of transitional cell carcinoma of the upper urinary tract. Urol Clin North Am 15:419\u2013424","journal-title":"Urol Clin North Am"},{"key":"949_CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-5347(17)70122-X","volume":"53","author":"SA Vest","year":"1945","unstructured":"Vest SA (1945) Conservative surgery in certain benign tumors of the ureter. J Urol 53:97\u2013120","journal-title":"J Urol"},{"key":"949_CR4","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.juro.2010.02.005","volume":"183","author":"AJ Gadzinski","year":"2010","unstructured":"Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 183:2148\u20132153. doi: 10.1016\/j.juro.2010.02.005","journal-title":"J Urol"},{"key":"949_CR5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0022-5347(05)67135-2","volume":"164","author":"GL Chen","year":"2000","unstructured":"Chen GL, Bagley DH (2000) Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 164:1173\u20131176","journal-title":"J Urol"},{"key":"949_CR6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2010.12.042","volume":"59","author":"M Roupret","year":"2011","unstructured":"Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R et al (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59:584\u2013594. doi: 10.1016\/j.eururo.2010.12.042","journal-title":"Eur Urol"},{"key":"949_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00345-009-0494-x","volume":"28","author":"JN Cornu","year":"2010","unstructured":"Cornu JN, Roupret M, Carpentier X, Geavlete B, de Medina SG, Cussenot O et al (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28:151\u2013156. doi: 10.1007\/s00345-009-0494-x","journal-title":"World J Urol"},{"key":"949_CR8","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0022-5347(01)64793-1","volume":"157","author":"FX Keeley Jr","year":"1997","unstructured":"Keeley FX Jr, Bibbo M, Bagley DH (1997) Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 157:1560\u20131565","journal-title":"J Urol"},{"issue":"Suppl 2","key":"949_CR9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1464-410X.2005.05210.x","volume":"95","author":"GB Johnson","year":"2005","unstructured":"Johnson GB, Fraiman M, Grasso M (2005) Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies. BJU Int 95(Suppl 2):110\u2013113","journal-title":"BJU Int"},{"key":"949_CR10","unstructured":"Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al (2011) Oxford Centre for Evidence-Based Medicine. The Oxford 2011 levels of evidence. http:\/\/www.cebm.net\/index.aspx?o=5653"},{"key":"949_CR11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1464-410X.2005.05402.x","volume":"95","author":"GD Stewart","year":"2005","unstructured":"Stewart GD, Bariol SV, Grigor KM, Tolley DA, McNeill SA (2005) A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int 95:791\u2013793. doi: 10.1111\/j.1464-410X.2005.05402.x","journal-title":"BJU Int"},{"key":"949_CR12","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester RJ, van der MA, Lamm DL (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168:1964\u20131970. doi: 10.1097\/01.ju.0000034450.80198.1c","journal-title":"J Urol"},{"key":"949_CR13","first-page":"765","volume":"21","author":"M Huncharek","year":"2001","unstructured":"Huncharek M, McGarry R, Kupelnick B (2001) Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Anticancer Res 21:765\u2013769","journal-title":"Anticancer Res"},{"key":"949_CR14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1464-410X.2004.04987.x","volume":"94","author":"JP O\u2019Donoghue","year":"2004","unstructured":"O\u2019Donoghue JP, Crew JP (2004) Adjuvant topical treatment of upper urinary tract urothelial tumours. BJU Int 94:483\u2013485. doi: 10.1111\/j.1464-410X.2004.04987.x","journal-title":"BJU Int"},{"key":"949_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-5347(17)44909-3","volume":"136","author":"PJ Helsdingen van","year":"1986","unstructured":"van Helsdingen PJ, Rikken CH (1986) Treatment of urothelial carcinoma of the upper urinary tract following prostatocystectomy with mitomycin C instillation in the ileal loop. J Urol 136:461\u2013463","journal-title":"J Urol"},{"key":"949_CR16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0022-5347(17)35473-3","volume":"150","author":"JA Eastham","year":"1993","unstructured":"Eastham JA, Huffman JL (1993) Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. J Urol 150:324\u2013325","journal-title":"J Urol"},{"key":"949_CR17","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/S0022-5347(01)68157-6","volume":"158","author":"FX Keeley Jr","year":"1997","unstructured":"Keeley FX Jr, Bagley DH (1997) Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma. J Urol 158:2074\u20132077","journal-title":"J Urol"},{"key":"949_CR18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0094-0143(21)01586-X","volume":"15","author":"E Orihuela","year":"1988","unstructured":"Orihuela E, Smith AD (1988) Percutaneous treatment of transitional cell carcinoma of the upper urinary tract. Urol Clin North Am 15:425\u2013431","journal-title":"Urol Clin North Am"},{"key":"949_CR19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0022-5347(17)45739-9","volume":"135","author":"ML Kock De","year":"1986","unstructured":"De Kock ML, Breytenbach IH (1986) Local excision and topical thiotepa in the treatment of transitional cell carcinoma of the renal pelvis: a case report. J Urol 135:566\u2013567","journal-title":"J Urol"},{"key":"949_CR20","doi-asserted-by":"crossref","unstructured":"Katz MH, Lee MW, Gupta M (2007) Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B. J Endourol 21:374\u2013377; discussion 377 doi: 10.1089\/end.2007.9969","DOI":"10.1089\/end.2007.9969"},{"key":"949_CR21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-5347(17)47277-6","volume":"134","author":"HW Herr","year":"1985","unstructured":"Herr HW (1985) Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. J Urol 134:531\u2013532","journal-title":"J Urol"},{"key":"949_CR22","doi-asserted-by":"crossref","unstructured":"Sharpe JR, Duffy G, Chin JL (1993) Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J Urol 149:457\u2013459; discussion 459-460","DOI":"10.1016\/S0022-5347(17)36117-7"},{"key":"949_CR23","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0022-5347(17)40230-8","volume":"143","author":"JC Ramsey","year":"1990","unstructured":"Ramsey JC, Soloway MS (1990) Instillation of bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma. J Urol 143:1220\u20131222","journal-title":"J Urol"},{"key":"949_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-5347(17)42346-9","volume":"139","author":"E Mukamel","year":"1988","unstructured":"Mukamel E, Layfield LJ, Hawkins RA, Dekernion JB (1988) The effect of bacillus Calmette-Guerin on the urinary system of pigs. J Urol 139:165\u2013169","journal-title":"J Urol"},{"key":"949_CR25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0022-5347(17)44272-8","volume":"137","author":"AD Smith","year":"1987","unstructured":"Smith AD, Orihuela E, Crowley AR (1987) Percutaneous management of renal pelvic tumors: a treatment option in selected cases. J Urol 137:852\u2013856","journal-title":"J Urol"},{"key":"949_CR26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0022-5347(17)38957-7","volume":"142","author":"UE Studer","year":"1989","unstructured":"Studer UE, Casanova G, Kraft R, Zingg EJ (1989) Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. J Urol 142:975\u2013977","journal-title":"J Urol"},{"key":"949_CR27","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0022-5347(05)64454-0","volume":"168","author":"GN Thalmann","year":"2002","unstructured":"Thalmann GN, Markwalder R, Walter B, Studer UE (2002) Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 168:1381\u20131385","journal-title":"J Urol"},{"key":"949_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2008.06.026","volume":"73","author":"AR Rastinehad","year":"2009","unstructured":"Rastinehad AR, Ost MC, Vanderbrink BA, Greenberg KL, El-Hakim A, Marcovich R et al (2009) A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guerin therapy? Urology 73:27\u201331. doi: 10.1016\/j.urology.2008.06.026","journal-title":"Urology"},{"key":"949_CR29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0022-5347(01)67632-8","volume":"153","author":"A Huang","year":"1995","unstructured":"Huang A, Low RK, White deVere R (1995) Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma. J Urol 153:1041\u20131042","journal-title":"J Urol"},{"key":"949_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0090-4295(01)01488-1","volume":"59","author":"A Irie","year":"2002","unstructured":"Irie A, Iwamura M, Kadowaki K, Ohkawa A, Uchida T, Baba S (2002) Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology 59:53\u201357","journal-title":"Urology"},{"key":"949_CR31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.ju.0000147747.89028.64","volume":"173","author":"O Yossepowitch","year":"2005","unstructured":"Yossepowitch O, Lifshitz DA, Dekel Y, Ehrlich Y, Gur U, Margel D et al (2005) Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation. J Urol 173:890\u2013893. doi: 10.1097\/01.ju.0000147747.89028.64","journal-title":"J Urol"},{"key":"949_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(01)64015-1","volume":"159","author":"A Patel","year":"1998","unstructured":"Patel A, Fuchs GJ (1998) New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. J Urol 159:71\u201375","journal-title":"J Urol"},{"key":"949_CR33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/end.2008.0164","volume":"23","author":"AR Rastinehad","year":"2009","unstructured":"Rastinehad AR, Smith AD (2009) Bacillus Calmette-Guerin for upper tract urothelial cancer: is there a role? J Endourol 23:563\u2013568. doi: 10.1089\/end.2008.0164","journal-title":"J Endourol"},{"key":"949_CR34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00184116","volume":"12","author":"B Schneider","year":"1994","unstructured":"Schneider B, Thanhauser A, Jocham D, Loppnow H, Vollmer E, Galle J et al (1994) Specific binding of bacillus Calmette-Guerin to urothelial tumor cells in vitro. World J Urol 12:337\u2013344","journal-title":"World J Urol"},{"key":"949_CR35","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0022-5347(01)66732-6","volume":"154","author":"TW Jarrett","year":"1995","unstructured":"Jarrett TW, Sweetser PM, Weiss GH, Smith AD (1995) Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J Urol 154:1629\u20131635","journal-title":"J Urol"},{"key":"949_CR36","doi-asserted-by":"crossref","unstructured":"Schoenberg MP, Van Arsdalen KN, Wein AJ (1991) The management of transitional cell carcinoma in solitary renal units. J Urol 146:700\u2013702; discussion 702-703","DOI":"10.1016\/S0022-5347(17)37897-7"},{"key":"949_CR37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0090-4295(99)80005-3","volume":"45","author":"SP Vasavada","year":"1995","unstructured":"Vasavada SP, Streem SB, Novick AC (1995) Definitive tumor resection and percutaneous bacille Calmette-Guerin for management of renal pelvic transitional cell carcinoma in solitary kidneys. Urology 45:381\u2013386","journal-title":"Urology"},{"key":"949_CR38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-5347(01)65854-3","volume":"156","author":"JA Martinez-Pineiro","year":"1996","unstructured":"Martinez-Pineiro JA, Garcia Matres MJ, Martinez-Pineiro L (1996) Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol 156:377\u2013385","journal-title":"J Urol"},{"key":"949_CR39","doi-asserted-by":"crossref","unstructured":"Clark PE, Streem SB, Geisinger MA (1999) 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol 161:772\u2013775; discussion 775-776","DOI":"10.1016\/S0022-5347(01)61765-8"},{"key":"949_CR40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","volume":"60","author":"G Giannarini","year":"2011","unstructured":"Giannarini G, Kessler TM, Birkhauser FD, Thalmann GN, Studer UE (2011) Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol 60:955\u2013960. doi: 10.1016\/j.eururo.2011.07.051","journal-title":"Eur Urol"},{"key":"949_CR41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0094-0143(05)70122-1","volume":"27","author":"ME Jabbour","year":"2000","unstructured":"Jabbour ME, Smith AD (2000) Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am 27:739\u2013750","journal-title":"Urol Clin North Am"},{"key":"949_CR42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1442-2042.2006.01312.x","volume":"13","author":"Y Kojima","year":"2006","unstructured":"Kojima Y, Tozawa K, Kawai N, Sasaki S, Hayashi Y, Kohri K (2006) Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guerin therapy. Int J Urol 13:340\u2013344. doi: 10.1111\/j.1442-2042.2006.01312.x","journal-title":"Int J Urol"},{"key":"949_CR43","doi-asserted-by":"crossref","unstructured":"Audenet F, Traxer O, Yates DR, Cussenot O, Roupret M (2012) Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract. BJU Int 109:608\u2013613; discussion 613-604 doi: 10.1111\/j.1464-410X.2011.10363.x","DOI":"10.1111\/j.1464-410X.2011.10363.x"},{"key":"949_CR44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/end.2009.0593","volume":"25","author":"O Traxer","year":"2011","unstructured":"Traxer O, Geavlete B, de Medina SG, Sibony M, Al-Qahtani SM (2011) Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience. J Endourol 25:19\u201323. doi: 10.1089\/end.2009.0593","journal-title":"J Endourol"},{"key":"949_CR45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O\u2019Brien","year":"2011","unstructured":"O\u2019Brien T, Ray E, Singh R, Coker B, Beard R (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 60:703\u2013710. doi: 10.1016\/j.eururo.2011.05.064","journal-title":"Eur Urol"},{"key":"949_CR46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1464-410x.2000.00610.x","volume":"85","author":"Y Nishino","year":"2000","unstructured":"Nishino Y, Yamamoto N, Komeda H, Takahashi Y, Deguchi T (2000) Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract. BJU Int 85:799\u2013801","journal-title":"BJU Int"},{"key":"949_CR47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-5347(17)34860-7","volume":"151","author":"GC Bellman","year":"1994","unstructured":"Bellman GC, Sweetser P, Smith AD (1994) Complications of intracavitary bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma. J Urol 151:13\u201315","journal-title":"J Urol"},{"key":"949_CR48","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1464-410X.1996.09559.x","volume":"77","author":"H Yokogi","year":"1996","unstructured":"Yokogi H, Wada Y, Mizutani M, Igawa M, Ishibe T (1996) Bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract. Br J Urol 77:676\u2013679","journal-title":"Br J Urol"},{"key":"949_CR49","doi-asserted-by":"crossref","unstructured":"Nonomura N, Ono Y, Nozawa M, Fukui T, Harada Y, Nishimura K et al (2000) Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur Urol 38:701\u2013704; discussion 705","DOI":"10.1159\/000020365"},{"key":"949_CR50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1464-410X.2001.02297.x","volume":"88","author":"K Okubo","year":"2001","unstructured":"Okubo K, Ichioka K, Terada N, Matsuta Y, Yoshimura K, Arai Y (2001) Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure. BJU Int 88:343\u2013347","journal-title":"BJU Int"},{"key":"949_CR51","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1442-2042.2002.00551.x","volume":"9","author":"H Miyake","year":"2002","unstructured":"Miyake H, Eto H, Hara S, Okada H, Kamidono S, Hara I (2002) Clinical outcome of bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract. Int J Urol 9:677\u2013680","journal-title":"Int J Urol"},{"key":"949_CR52","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.urology.2004.01.046","volume":"63","author":"Y Hayashida","year":"2004","unstructured":"Hayashida Y, Nomata K, Noguchi M, Eguchi J, Koga S, Yamashita S et al (2004) Long-term effects of bacille Calmette-Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract. Urology 63:1084\u20131088. doi: 10.1016\/j.urology.2004.01.046","journal-title":"Urology"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-012-0949-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-012-0949-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-012-0949-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T14:36:09Z","timestamp":1643466969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-012-0949-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,25]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["949"],"URL":"https:\/\/doi.org\/10.1007\/s00345-012-0949-3","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,25]]}}}